EcoDrugPlus

Integrin Subunit Alpha 4

Ensembl ID : ENSOKIG00005036271
Gene Symbol: ITGA4
3 Cross references
219 Possible Orthologues:

Integrin Subunit Alpha 4

Ensembl ID : ENSOKIG00005004923
Gene Symbol: ITGA4
3 Cross references
219 Possible Orthologues:

Integrin Subunit Alpha 5

Ensembl ID : ENSOKIG00005034829
Gene Symbol: ITGA5
3 Cross references
191 Possible Orthologues:

Integrin Subunit Alpha 5

Ensembl ID : ENSOKIG00005018969
Gene Symbol: ITGA5
3 Cross references
190 Possible Orthologues:

Integrin Subunit Beta 1

Ensembl ID : ENSOKIG00005039759
Gene Symbol: ITGB1
3 Cross references
223 Possible Orthologues:

Integrin Subunit Beta 1

Ensembl ID : ENSOKIG00005050647
Gene Symbol: ITGB1
3 Cross references
223 Possible Orthologues:

Integrin Subunit Beta 3

Ensembl ID : ENSOKIG00005008867
Gene Symbol: ITGB3
3 Cross references
194 Possible Orthologues:

Integrin Subunit Beta 6

Ensembl ID : ENSOKIG00005004992
Gene Symbol: ITGB6
3 Cross references
204 Possible Orthologues:

Integrin Subunit Beta 6

Ensembl ID : ENSOKIG00005036724
Gene Symbol: ITGB6
3 Cross references
203 Possible Orthologues:

Integrin Subunit Beta 7

Ensembl ID : ENSOKIG00005024628
Gene Symbol: ITGB7
3 Cross references
145 Possible Orthologues:

Integrin Subunit Beta 8

Ensembl ID : ENSOKIG00005006810
Gene Symbol: ITGB8
2 Cross references
199 Possible Orthologues:

Integrin, Alpha V

Ensembl ID : ENSOKIG00005040059
Gene Symbol: ITGAV
1 Cross references
225 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).